AWARDS. Assar Gabrielsson’s prize is awarded for 2023 to two excellent doctoral theses in cancer research within Region Västra Götaland. Now you can see the pictures from the award ceremony, which was held on Tuesday 23 May 2023. This year’s award winners are Malin Lindén (basic scientific research) and Aron Onerup (clinical research). The prize winners receive an extra research grant of SEK 100,000 each. Malin Lindén has studied how…
Thirty-three researchers receive funding from Jubilee Clinic’s Cancer Fund
GRANTS. This year, the Jubilee Clinic’s Cancer Fund is awarding approximately SEK 16.2 million for cancer research at, or in connection with, the Jubilee Clinic at Sahlgrenska University Hospital. Of this amount, about SEK 1.2 million relates to research months for clinically active researchers. One of the 33 researchers receiving funding is Cecilia Bull, who will receive SEK 400,000 per year for two years. Her team is mapping what happens…
Possible new cancer treatment target discovered
NEW STUDY. Researchers at the University of Gothenburg have identified a previously unknown mechanism controlling tumor growth in cultured cells and mice. This discovery may potentially enable future development of new drugs against a range of cancer diseases. In a research article published in the journal Nature Communications, the Gothenburg scientists have described their discovery. It concerns a protein that binds genetic material and, as the researchers now show, also…
New marker predicts benefit of radiotherapy for early-stage breast cancer
NEW STUDY. A study involving researchers at University of Gothenburg and Karolinska Institutet in Sweden has found that low levels of a protein called PDGFRb are associated with particularly good results of radiotherapy in women with early-stage breast cancer. The study, which is published in the journal Clinical Cancer Research, also suggests that the efficacy of radiotherapy can be improved with drugs that block this protein. Some 900 women in…
Serious form of melanoma gene-sequenced
STUDY. Researchers at Sahlgrenska Academy and Sahlgrenska University Hospital have mapped the genome of metastases from uveal melanoma, a rare but severe form of malignant melanoma that originates in the eye. The knowledge provided by this gene mapping includes new insights into how metastases arise and the nature of tumor-infiltrating immune cells. The study, now published in Nature Communications, provides hope for new approaches to combating this form of tumor.…